Ireland vs Japan: Cause of death, by non-communicable diseases, ages 0-4, male
Ireland
54.6%
in 2021
Japan
60.1%
in 2021
Ireland rank
4th
Japan rank
1st
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Ireland
- Japan
How they compare
Japan currently reports 60.1% against 54.6% in Ireland, a difference of 5.5%.
That makes Japan's figure about 1.1 times Ireland's.
Across all 6 years both countries report, Japan has been ahead every year.
Ireland ranks 4th and Japan ranks 1st of 185 countries.
Japan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ireland | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.1% | 54.8% | 1.7% | Japan |
| 2010s | 54.2% | 60.0% | 5.8% | Japan |
| 2020s | 55.0% | 60.1% | 5.0% | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Ireland or Japan?
- Japan, at 60.1% against 54.6% in Ireland as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Ireland and Japan?
- 5.5%, with Japan ahead.
- How many years of comparable data are there for Ireland and Japan?
- 6 years are reported by both, from 2000 to 2021.
- How do Ireland and Japan rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Ireland ranks 4th and Japan ranks 1st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.